Cargando…

Comparing the efficacy and safety of second-line therapies for advanced hepatocellular carcinoma: a network meta-analysis of phase III trials

BACKGROUND: The prospect for targeted therapies in advanced hepatocellular carcinoma (HCC) has dramatically changed since several recent clinical trials have yielded promising results. The number of second-line therapies is increasing, though the consequent challenge is to consider differences betwe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Dongxu, Yang, Xu, Lin, Jianzhen, Bai, Yi, Long, Junyu, Yang, Xiaobo, Seery, Samuel, Zhao, Haitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Diagnosis, Management, and Prognostic Assessment of Liver Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313339/ https://www.ncbi.nlm.nih.gov/pubmed/32636928 http://dx.doi.org/10.1177/1756284820932483

Ejemplares similares

Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis
por: Liang, Lei, et al.
Publicado: (2020)

Locoregional therapies in patients with recurrent intrahepatic cholangiocarcinoma after curative resection
por: Liu, Hsiao-Tien, et al.
Publicado: (2020)

Is there a common latent cognitive construct for dementia estimation across two Chinese cohorts?
por: Liu, Yuyang, et al.
Publicado: (2022)

Exploring discordant low amyloid beta and high neocortical tau positron emission tomography cases
por: Krishnadas, Natasha, et al.
Publicado: (2022)

Comorbidity patterns in institutionalized older adults affected by dementia
por: Zazzara, Maria Beatrice, et al.
Publicado: (2022)

A proposed theoretical framework for retinal biomarkers
por: MacCormick, Ian James Callum, et al.
Publicado: (2022)

Stronger implicit interference in cognitively healthy older participants with higher risk of Alzheimer's disease
por: Hung, Shao‐Min, et al.
Publicado: (2022)

Weight loss in a cardiovascular trial population identifies people at future risk of dementia
por: van der Veere, Pieter, et al.
Publicado: (2022)

Development and design of a diagnostic report to support communication in dementia: Co‐creation with patients and care partners
por: van Gils, Aniek M., et al.
Publicado: (2022)

Medicare's Annual Wellness Visit and diagnoses of dementias and cognitive impairment
por: Thunell, Johanna A., et al.
Publicado: (2022)

Mayo normative studies: A conditional normative model for longitudinal change on the Auditory Verbal Learning Test and preliminary validation in preclinical Alzheimer's disease
por: Alden, Eva C., et al.
Publicado: (2022)

Development and implementation of an electronic Clinical Dementia Rating and Financial Capacity Instrument‐Short Form
por: Howell, Taylor, et al.
Publicado: (2022)

No difference in retinal fluorescence after oral curcumin intake in amyloid‐proven AD cases compared to controls
por: den Haan, Jurre, et al.
Publicado: (2022)

Optimizing cCOG, a Web‐based tool, to detect dementia with Lewy Bodies
por: van Gils, Aniek M., et al.
Publicado: (2022)

Evaluation of blood‐based, extracellular vesicles as biomarkers for aging‐related TDP‐43 pathology
por: Winston, Charisse N., et al.
Publicado: (2022)

Life satisfaction across the entire trajectory of Alzheimer's disease: A mediation analysis
por: Mank, Arenda, et al.
Publicado: (2022)

Memory‐driven eye movements prospectively predict dementia in people at risk of Alzheimer's disease
por: Parra, Mario A, et al.
Publicado: (2022)

Sex‐specific biomarkers in Alzheimer's disease progression: Framingham Heart Study
por: Liu, Chunyu, et al.
Publicado: (2022)

Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second‐line clinical trials
por: Tovoli, Francesco, et al.
Publicado: (2021)

The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal Melanoma
por: Harbour, J. William, et al.
Publicado: (2013)

Social connectedness, mindfulness, and coping as protective factors during the COVID‐19 pandemic
por: Dailey, Stephanie F., et al.
Publicado: (2022)

Hypomethylation of long interspersed nuclear element-1 promoter is associated with poor outcomes for curative resected hepatocellular carcinoma
por: Gao, Xu-dong, et al.
Publicado: (2014)

Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
por: Park, Joong-Won, et al.
Publicado: (2015)

Preoperative evaluation of microvascular invasion with circulating tumour DNA in operable hepatocellular carcinoma
por: Wang, Dong, et al.
Publicado: (2020)

Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies
por: Wang, Dongxu, et al.
Publicado: (2019)

Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab
por: Reig, Maria, et al.
Publicado: (2020)

Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
por: Vithayathil, Mathew, et al.
Publicado: (2022)

A multicentre retrospective analysis on growth of residual hepatocellular adenoma after resection
por: Klompenhouwer, Anne J., et al.
Publicado: (2020)

Hepatocellular adenoma in men: A nationwide assessment of pathology and correlation with clinical course
por: van Rosmalen, Belle V., et al.
Publicado: (2021)

Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib
por: Labeur, Tim A., et al.
Publicado: (2019)

Ribociclib enhances infigratinib‐induced cancer cell differentiation and delays resistance in FGFR‐driven hepatocellular carcinoma
por: Prawira, Aldo, et al.
Publicado: (2020)

Alcohol‐related hepatocellular carcinoma is a heterogenous condition: Lessons from a latent class analysis
por: Costentin, Charlotte E., et al.
Publicado: (2022)

Predicting microvascular invasion in hepatocellular carcinoma: A dual‐institution study on gadoxetate disodium‐enhanced MRI
por: Jiang, Hanyu, et al.
Publicado: (2022)

Interaction of FGF9 with FGFR3‐IIIb/IIIc, a putative driver of growth and aggressive behaviour of hepatocellular carcinoma
por: Paur, Jakob, et al.
Publicado: (2020)

Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenib
por: Choi, Joon-Il, et al.
Publicado: (2014)

Peripheral blood and tissue assessment highlights differential tumor-circulatory gradients of IL2 and MIF with prognostic significance in resectable pancreatic ductal adenocarcinoma
por: Ahmed, Azaz, et al.
Publicado: (2021)

Multicentre, phase II study of gemcitabine and S‐1 in patients with advanced biliary tract cancer: TG1308 study
por: Chiang, Nai‐Jung, et al.
Publicado: (2020)

The Efficacy and Safety of Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer: A Prospective Clinical Study
por: Wang, Dongxu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aom5ipk6r4rgqdn6gsmhkc3dj0